Effects of Metformin on Pregnancy Outcomes in Gestational Diabetes
Official title: Pregnancy Outcomes: Effects of Metformin Study (POEM Study), a Long Term Randomized Controlled Study in Gestational Diabetes
Run by Bethesda Diabetes Research Center · NCT02947503 · Data updated 2026-11-12
This study tests if taking metformin along with diet and lifestyle changes can improve pregnancy outcomes for women with gestational diabetes and their babies.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 500 (estimated) |
| Sponsor | Bethesda Diabetes Research Center Academic / other |
| Locations | 4 sites (Groningen and 3 other locations) |
| Status | Recruiting |
| Started | November 26, 2019 |
| Main results expected | December 2043 |
| Study ends | December 2043 |
| Registry record updated | February 10, 2022 |
| Trial ID | NCT02947503 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18-45 with a diagnosis of gestational diabetes between 16-32 weeks of gestation.
✕Probably not a fit
Patients with pre-existing diabetes, severe renal or liver disease, or significant psychiatric disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The POEM study investigates the impact of metformin on pregnant women diagnosed with gestational diabetes mellitus (GDM). This randomized controlled trial compares two groups: one receiving metformin alongside diet and lifestyle changes, and the other receiving diet and lifestyle changes alone. The study aims to assess various pregnancy outcomes at delivery and long-term health effects for both mother and child. It consists of three phases, including an observational extension to evaluate outcomes up to 20 years post-delivery.
Why it matters
Potential benefit: If successful, this study could significantly reduce complications associated with gestational diabetes for both mothers and their children.
How similar studies have gone: Previous observational studies suggest potential benefits of metformin in managing gestational diabetes, but this is the first randomized controlled trial of its kind.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women with GDM defined as a Fasting Plasma Glucose (FPG) \> 5,3 mMol and/or an Oral Glucose Tolerance test (OGTT) with a Plasma glucose (PG) \> 7,8 mMol, two hours after the oral intake of 75 gram glucose * Written informed consent * Age 18-45 years * Gestational age at inclusion 16-32 weeks * Glycohemoglobin test (HbA1c) at inclusion ≤ 48 mmol/mol (6.5% Hb) Exclusion Criteria: * Diabetes mellitus before pregnancy, except previous GDM * Proteinuria: Urine Albumin-to-Creatinine Ratio (UACR) \> 35 mg/mmol at screening * Malignancy during the last 5 years before inclusion, except non-melanoma skin cancer * Psychiatric and/or mood disorder potentially affecting compliance of treatment * Chronic liver disease and/or Alanine aminotransferase aspartate transaminase (ASAT) and/or Alanine aminotransferase (ALAT) \> 3x Upper Limit of Normal (ULN). * Chronic renal failure with a Glomerular filtration rate (GFR) \< 45 ml/min/1.73m2 * Chronic pulmonary failure with hypoxia * Significantly uncontrolled hypertension - Systolic blood pressure (SBP) \> 160 mm Hg despite medical treatment * Chronic treatment with corticosteroids * Intolerance for metformin and/or earlier use of metformin in this pregnancy * Membership of the POEM study group * Severe foetal anomaly at inclusion - like major neural tube and/or cardiac malformation * Ruptured membranes * Multiple pregnancy * Inability to understand or read the Dutch language * Bariatric surgery in medical history * Hyperemesis gravidarum
Where it's running
-
Martini hospital Groningen
Groningen, Netherlands Recruiting -
University Medical Center Groningen
Groningen, Netherlands Recruiting -
Treant Zorggroep
Hoogenveen, Emmen, Stadskanaal, Netherlands Recruiting -
Medical Center Leeuwarden
Leeuwarden, Netherlands Recruiting
Study contacts
- Principal investigator: Adriaan Kooy, Dr. — Bdrc
- Study coordinator: Adriaan Kooy, Dr
- Email: a.kooy@treant.nl
- Phone: +31528286859
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Early Glucose Patterns in Pregnant Women at Risk for GDM
This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.